PREDICTION OF PROMISCUOUS EPITOPE STUDIES OF SPA ANTIGEN IN STAPHYLOCOCCUS AUREUS: AN INSIGHT ON PEPTIDE-BASED VACCINE
Keywords:
Epitope, SPA antigen, IgG antibody, docking studiesAbstract
Objective: Owing to the difficulty in providing drug therapies against Methicillin-resistant Staphylococcus aureus (MRSA), the development of an effective and promising vaccine is an immense challenge in combatingMRSA infections. The present work focuses on the development of a peptide-based vaccine, by identifying the epitopes from SPA antigen.
Methods: The epitopes were identified based on different properties, such that they are capable of eliciting broadly neutralizing immune responses. The identified epitopes were subjected for peptide docking using Glide and antibody-antigen docking using ClusPro.
Results: By in silico approach two epitopes NLNEEQRNG†and LKDDPSQSAN†were identified for SPA protein with sequence lengths of nine and ten respectively. The least energy for the peptide docking was observed for NLNEEQRNG sequence and the amino acid residues of this peptide share similar interaction with antibody-antigen docking.
Conclusion: Based on the properties and docking studies the best-ranked epitope sequence is ‘NLNEEQRNG'. Further studies on this peptide sequence might be helpful for alternative therapy of MRSA infections.
Keywords: Epitope, SPA antigen, IgG antibody, Docking studies
Downloads
References
Van Hal SJ, Jensen SO, Vaska VL, Espedido BA, Paterson DL, Gosbell IB. Predictors of mortality in staphylococcus aureus bacteremia. Clin Microbiol Rev 2012;25:362–86.
Yeaman MR, Filler SG, Schmidt CS, Ibrahim AS, Edwards JE, Hennessey JP. Applying convergent immunity to innovative vaccines targeting staphylococcus aureus. Front Immunol 2014;5:463.
Navarre WW, Schneewind O. Proteolytic cleavage, and cell wall anchoring at the LPXTG motif of surface proteins in gram-positive bacteria. Mol Microbiol 1994;14:115–21.
McDevitt D, Francois P, Vaudaux P, Foster TJ. Molecular characterization of the clumping factor (fibrinogen receptor) of Staphylococcus aureus. Mol Microbiol 1994;11:237–48.
Atkins KL, Burman JD, Chamberlain ES, Cooper JE, Poutrel B, Bagby S, et al. S. aureus IgG-binding proteins SpA and Sbi: host specificity and mechanisms of immune complex formation. Mol Immunol 2008;45:1600–11.
Graille M, Stura EA, Corper AL, Sutton BJ, Taussig MJ, Charbonnier JB, et al. Crystal structure of a staphylococcus aureus protein A domain complexed with the Fab fragment of a human IgM antibody: structural basis for recognition of B-cell receptors and superantigen activity. Proc Natl Acad Sci USA 2000;97:5399–404.
Romagnani S, Giudizi MG, del Prete G, Maggi E, Biagiotti R, Almerigogna F, et al. Demonstration on protein A of two distinct immunoglobulin-binding sites and their role in the mitogenic activity of Staphylococcus aureus Cowan I on human B cells. J Immunol 1982;129:596–602.
Dossett JH, Kronvall G, Williams RC, Quie PG. Antiphagocytic effects of staphylococcal protein A. J Immunol 1969;103:1405–10.
Flower DR. Designing immunogenic peptides. Nat Chem Biol 2013;9:749–53.
Hailemichael Y, Overwijk WW. Peptide-based anticancer vaccines: the making and unmaking of a T-cell graveyard. Oncoimmunology 2013;2:e24743.
Sause WE, Buckley PT, Strohl WR, Lynch AS, Torres VJ. Antibody-based biologics and their promise to combat staphylococcus aureus infections. Trends Pharmacol Sci 2015;37:231–41.
Tatusova T, Ciufo S, Fedorov B, O’Neill K, Tolstoy I. Ref Seq microbial genomes database: new representation and annotation strategy. Nucleic Acids Res 2014;42:D553–9.
Pruitt K, Brown G, Tatusova T, Maglott D. The reference sequence (RefSeq) Database [Internet]. National Center for Biotechnology Information (US); 2012. Available: http:// www.ncbi.nlm.nih.gov/books/NBK21091. [Last accessed on 01 Feb 2015].
Mitchell A, Chang HY, Daugherty L, Fraser M, Hunter S, Lopez R, et al. The InterPro protein families database: the classification resource after 15 y. Nucleic Acids Res 2014;43:D213–21.
Vita R, Overton JA, Greenbaum JA, Ponomarenko J, Clark JD, Cantrell JR, et al. The immune epitope database (IEDB) 3.0. Nucleic Acids Res 2015;43:D405–12.
Kolaskar AS, Tongaonkar PC. A semi-empirical method for prediction of antigenic determinants on protein antigens. FEBS Lett 1990;276:172–4.
Larsen JEP, Lund O, Nielsen M. Improved method for predicting linear B-cell epitopes. Immunome Res 2006;2:2.
Emini EA, Hughes JV, Perlow DS, Boger J. Induction of hepatitis a virus-neutralizing antibody by a virus-specific synthetic peptide. J Virol 1985;55:836–9.
Chou PY, Fasman GD. Prediction of the secondary structure of proteins from their amino acid sequence. Adv Enzymol Relat Areas Mol Biol 1978;47:45–148.
Karplus PA, Schulz GE. Prediction of chain flexibility in proteins. Naturwissenschaften 1985;72:212–3.
Parker JM, Guo D, Hodges RS. New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data: correlation of predicted surface residues with antigenicity and X-ray-derived accessible sites. Biochemistry 1986;25:5425–32.
Zhu K, Day T, Warshaviak D, Murrett C, Friesner R, Pearlman D. Antibody structure determination using a combination of homology modeling, energy-based refinement, and loop prediction. Proteins 2014;82:1646–55.
Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT, et al. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 2004;47:1739–49.
Watts KS, Dalal P, Murphy RB, Sherman W, Friesner RA, Shelley JC. ConfGen: a conformational search method for efficient generation of bioactive conformers. J Chem Inf Model 2010;50:534–46.
Tubert-Brohman I, Sherman W, Repasky M, Beuming T. Improved docking of polypeptides with Glide. J Chem Inf Model 2013;53:1689–99.
Comeau SR, Gatchell DW, Vajda S, Camacho CJ. ClusPro: an automated docking and discrimination method for the prediction of protein complexes. Bioinformatics 2004;20:45–50.
Kozakov D, Brenke R, Comeau SR, Vajda S. PIPER: an FFT-based protein docking program with pairwise potentials. Proteins 2006;65:392–406.
Saphire EO, Parren PW, Pantophlet R, Zwick MB, Morris GM, Rudd PM, et al. Crystal structure of a neutralizing human IGG against HIV-1:a template for vaccine design. Science 2001;293:1155–9.
Deis LN, Pemble CW, Qi Y, Hagarman A, Richardson DC, Richardson JS, et al. Multiscale conformational heterogeneity in staphylococcal protein a: possible determinant of functional plasticity. Structure 2014;22:1467–77.
Schmidt MA. Development and application of synthetic peptides as vaccines. Biotechnol Adv 1989;7:187–213.
Wang JG, Jansen RW, Brown EA, Lemon SM. Immunogenic domains of hepatitis delta virus antigen: peptide mapping of epitopes recognized by human and woodchuck antibodies. J Virol 1990;64:1108–16.
Gavin AL, Hoebe K, Duong B, Ota T, Martin C, Beutler B, et al. Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling. Science 2006;314:1936–8.
Flower DR. Immunoinformatics and the in silico prediction of immunogenicity. An introduction. Methods Mol Biol 2007;409:1–15.
Jha AN, Vishveshwara S, Banavar JR. Amino acid interaction preferences in proteins. Protein Sci 2010;19:603–16.
Schulze-Gahmen U, Prinz H, Glatter U, Beyreuther K. Towards assignment of secondary structures by anti-peptide antibodies. Specificity of the immune response to a beta-turn. EMBO J 1985;4:1731–7.
Fieser TM, Tainer JA, Geysen HM, Houghten RA, Lerner RA. Influence of protein flexibility and peptide conformation on the reactivity of monoclonal anti-peptide antibodies with a protein alpha-helix. Proc Natl Acad Sci USA 1987;84:8568–72.